Dashboard
Manage Tickers

LPTXLEAP THERAPEUTICS, INC.

Nasdaq leaptx.com


$ 2.76 $ -0.13 (-4.47 %)    

Friday, 10-May-2024 15:54:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.62 $ -0.63 (-0.14 %)
DIA $ 395.58 $ -0.80 (-0.2 %)
SPY $ 520.82 $ -1.75 (-0.33 %)
TLT $ 90.33 $ 0.00 (0 %)
GLD $ 216.12 $ -1.07 (-0.49 %)
$ 2.78
$ 2.92
$ 0.00 x 0
$ 0.00 x 0
$ 2.74 - $ 2.92
$ 1.24 - $ 10.20
125,413
na
75.1M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-18-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

leap-therapeutics-says-net-proceeds-from-april-2024-372m-financing-combined-with-existing-cash-cash-equivalents-and-marketable-securities-of-549m-are-expected-to-provide-cash-runway-into-the-second-quarter-of-2026
Leap Therapeutics Says Net Proceeds From A...
05/13/2024 11:11:38

leap-therapeutics-q1-2024-gaap-eps-051-beats-058-estimate
Leap Therapeutics Q1 2024 GAAP EPS $(0.51)...
05/13/2024 11:09:19

Core News & Articles
Leap Therapeutics 13G Filing Shows Gilead ...
04/19/2024 20:43:40

- SEC Filing

leap-therapeutics-announces-40m-private-placement
Leap Therapeutics Announces $40M Private P...
04/11/2024 12:33:23

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/20/2024 21:34:27

baird-maintains-outperform-on-leap-therapeutics-lowers-price-target-to-9
Baird Maintains Outperform on Leap Therape...
03/19/2024 11:09:53

Baird analyst Joel Beatty maintains Leap Therapeutics (NASDAQ:LPTX) with a Outperform and lowers the price target from $11 t...

hc-wainwright--co-reiterates-buy-on-leap-therapeutics-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Leap...
03/19/2024 10:48:02

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and maintains $...

leap-therapeutics-q4-earnings-insights
Leap Therapeutics: Q4 Earnings Insights
03/18/2024 15:10:06

leap-therapeutics-q4-eps-046-beats-055-estimate-cash-balance-of-706m
Leap Therapeutics Q4 EPS $(0.46) Beats $(0...
03/18/2024 11:19:08

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0...

leap-therapeutics-concludes-enrollment-in-the-randomized-controlled-part-c-of-distinguish-study-of-dkn-01-in-combination-with-beigenes-tislelizumab-and-chemotherapy-in-patients-with-advanced-gastroesophageal-junction-and-gastric-cancer
Leap Therapeutics Concludes Enrollment In ...
01/02/2024 12:03:14

leap-therapeutics-to-present-new-data-from-part-a-of-the-defiance-study-of-dkn-01-plus-bevacizumab-and-chemotherapy-in-colorectal-cancer-patients-at-the-2024-asco-gastrointestinal-cancers-symposium
Leap Therapeutics To Present New Data From...
12/11/2023 21:12:52

Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
11/27/2023 21:31:02

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
11/24/2023 17:31:07

why-flj-group-shares-are-trading-higher-by-around-96-here-are-other-stocks-moving-in-fridays-mid-day-session
Why FLJ Group Shares Are Trading Higher By...
11/24/2023 17:21:14

Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a d...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/21/2023 17:31:04

mizuho-maintains-buy-on-leap-therapeutics-lowers-price-target-to-12
Mizuho Maintains Buy on Leap Therapeutics,...
11/20/2023 15:40:36

Mizuho analyst Mara Goldstein maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $20 to $12.

raymond-james-maintains-outperform-rating-for-leap-therapeutics-heres-what-you-need-to-know
Raymond James Maintains Outperform Rating ...
11/14/2023 17:00:35

raymond-james-maintains-outperform-on-leap-therapeutics-lowers-price-target-to-175
Raymond James Maintains Outperform on Leap...
11/14/2023 08:42:40

Raymond James analyst Steven Seedhouse maintains Leap Therapeutics (NASDAQ:LPTX) with a Outperform and lowers the price targ...

recap-leap-therapeutics-q3-earnings
Recap: Leap Therapeutics Q3 Earnings
11/13/2023 12:20:05

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
10/16/2023 13:05:49

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION